A 2026 biopharmaceutical review in a journal I do not trust said there is no identified high-affinity receptor, no validated molecular target, and a wide disconnect between the tidy preclinical effects and any coherent pharmacology
doi:10.1577/1548-8640(1997)059 2.3.co;2
The muscle lost during monotherapy must eventually be rebuilt, requiring additional time and effort
Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G, Lipscombe LL: Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study
Amino acid mutations in the H-site can significantly alter the catalytical activity of GST enzymes towards their substrates [88, 89]